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The CD4 glycoprotein serves as a receptor for the human immunodeficiency virus HIV, the etiologic agent of acquired immunodeficiency s ndrome 
(AIDS). We have examined the expression of CD4 molecules in a clone (HT29D4) derived from a human colon adenocarcinoma cell line. HT29-D4 
cells synthesized a 60 kDa polypeptide immunoprecipitated with two anti-CD4 monoclonal antibodies after metabolic or cell surface labeling. This 
60 kDa polypeptide was also immunodetected using the same antibodies in human acute lymphoblastic leukemia cells CEM which are known 
to express CD4. HT29D4 cells can be induced to differentiate into enterocyte-like cells by removing glucose from the culture medium. Under 
these conditions, HT29-D4 cells form a polarized epithelial monolayer in which tight junctions separate the plasma membrane in an apical and 
a basolateral domain. The localization of CD4 molecules in differentiated HT29D4 cells was exclusively restricted to the basolateral membrane 
domain as demonstrated by radioimmunoassay nd indirect immunofluorescence studies. Therefore the HT29D4 clonal cell line represents aunique 
model for polarized HIV infection of colonic epithelial cells and may be useful to understand some of the gastrointestinal disorders occurring in 
AIDS patients. 
1. INTRODUCTION 
CD4 is a glycoprotein of approximately 60 kDa ex- 
pressed on the cell membrane of a helper/inducer 
subset of human T lymphocytes [l] and, to a lesser ex- 
tent, on cells of the monocyte/macrophage lineage [2] 
and on eosinophils [3]. Despite its demonstrated role in 
T-cell-activation, little is known about he biology of 
CD4. Several lines of evidence suggest that CD4 binds 
to the class II MHC antigen HLA-DR thereby augmen- 
ting T-cell-activation [4]. An association between CD4 
and the T-cell receptor (TcR) has been demonstrated on 
the basis of cross-linking experiments [5] and an im- 
plication of the molecule in the transduction of in- 
tracellular signal has been recently proposed [6]. CD4 
is also known to bind the envelope glycoprotein gp120 
of the human immunodeficiency virus HIV-I [7], acting 
as a cellular receptor for HIV-l [8] and HIV-2 [9]. 
Among the clinical features of the acquired im- 
munodeficiency syndrome (AIDS), enteropathies like 
diarrhea, malabsorption, enteritis and proctitis are 
common [lo-121. Recently, Adachi et al. [13] 
demonstrated that the human colon adenocarcinoma 
cell line HT29 was susceptible to HIV infection. 
However, only a small fraction (up to 0.1%) of these 
cells could be directly infected with HIV, in agreement 
with a weak expression of CD4 mRNA [13]. Moreover 
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the authors failed to detect the presence of CD4 pro- 
teins on the surface of HT29 cells [13]. 
Since it is well established that HT29 is a 
heterogenous cell line [ 14,151, we looked to study the 
expression of the CD4 antigen in a well-characterized 
cell clone (HT29-D4) derived from HT29 cells by limit 
dilution technique [161. This clone represents avaluable 
model to study morphological and biochemical events 
associated with the process of enterocytic differentia- 
tion because it can be induced to differentiate by a sim- 
ple alteration of the culture medium (i.e. the 
replacement of glucose by galactose) [17,181. 
In this report, we demonstrate that: (i) CD4 proteins 
are synthesized by undifferentiated HT29-D4 cells, as 
demonstrated by radioimmunoprecipitation studies 
after metabolic or cell surface labeling; (ii) CD4 
molecules are restricted to the basolateral membrane of 
differentiated HT29-D4 cells. Therefore this cell line 
would prove to be a useful model for in vitro infection 
of colonic epithelial cells by HIV. 
2. MATERIALS AND METHODS 
2.1. Antibodies and reagents 
Monoclonal anti-CEA antibody MAC 601 was obtained from 
Biosys (Compiegne, France). Monocloncal anti-alkaline phosphatase 
antibody was obtained from Peninsula Laboratories (Belmont, CA). 
Monoclonal anti-villin (ID2C3), anti-HLA class I (B9.12.1), anti- 
CD4 (13B8.2 and B14) antibodies were from Immunotech (Marseille, 
France). Mouse IgG and rabbit anti-mouse IgGi were from Nordic 
Immunological Laboratories (Tilburg, The Netherlands). Bovine 
serum albumin (BSA), lactoperoxidase and Protein A-Sepharose 
were purchased from Sigma (St. Louis, MQ). Ca*+-free medium (S- 
MEM) was from Gibco (Grand Island, NY). All other cell culture 
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media and supplements were from Eurobio (Paris, France). L- 
[35S]Methionine and Nalz51 were purchased from Amersham (Les 
Ulis, France). %Protein A was a generous gift of Dr G. Rougon 
(CNRS URA 202, Marseille, France). 
2.2. Cell culture 
HT29 cells were obtained from Dr A. Zweibaum (INSERM Ul78, 
Villejuif, France) and cloned in our laboratory [16]. HT29-D4 clonal 
cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
containing 25 mM glucose and 10% fetal bovine serum (FBS) (undif- 
ferentiated cells). To induce the differentiation of HT29-D4 cells, the 
glucose-containing medium was replaced by glucose-free DMEM 
supplemented with 5 mM galactose and 10% dialysed FBS. 
Thereafter the cells were subcultured in this medium and referred to 
as differentiated cells. Human acute lymphoblastic leukemia cells of 
the line CEM were routinely grown in RPM1 1640 supplemented with 
10% FBS. 
2.3. Cell surface iodination 
HT29-D4 and CEM cells were radioiodinated in the presence of 
lactoperoxidase as previously described [19] according to Coding 
WV. 
2.4. Metabolic labeling 
HT29-D4 cells growing in 75 cm2 flasks (5 x lo7 cells) were in- 
cubated for 1 h at 37°C with 5 ml of methionine-free DMEM, after 
which L-[“Slmethionine was added to a final concentration of 
2OOpCi.m1-‘. After 3 h at 37”C, cells were washed twice with 
phosphate-buffered saline (PBS), pH 7.4. 
2.5. Itnmunoprecipitation and electrophoresis 
Cell surface or metabolically labeled cells were solubilized for 1 h 
at 4°C in the presence of buffer A (50 mM Tris-HCl, pH 8, 150 mM 
NaCl, 1 mM phenylmethylsulfonyl fluoride and 2 mM benzamidine). 
Lysates were precleared by centrifugation (10 min, 10000 x g). To 
reduce non-specific binding to the immunoadsorbent, cell lysates 
were also cleared by incubation with mouse IgG in the presence of 
Protein A-Sepharose at 4°C with shaking for 6 h. The mixture was 
centrifuged in an Eppendorf microcentrifuge for 2 min. Aliquots of 
the supernatant were incubated with the different monoclonal an- 
tibodies used in this study and Protein A-Sepharose at 4°C and 
shaken overnight. The monoclonal antibody 13B8.2 was insolubilized 
in the presence of rabbit anti-mouse IgGl polyclonal antibodies. Im- 
munoprecipitates were washed 3 times with buffer A, then twice with 
the same buffer containing 500 mM NaCl, once again in buffer A 
and finally resuspended in electrophoresis ample buffer. The im- 
munoprecipitated material was analysed by SDS-PAGE according to 
Laemmli [21]. The gel was dried and exposed to Fuji X-ray film with 
an intensifying screen (Du Pont). 
2.6. Binding studies 
Differentiated HT29-D4 cells were grown at confluency in 2 cm2 
well multidish plates in the presence of glucose-free, galactose- 
containing medium. Cell monolayers were rinsed twice in PBS 0.1% 
BSA and incubated for 2 h at 13°C with the indicated monoclonal 
antibody. Cells were then washed twice with PBS 0.1% BSA and in- 
cubated with ‘251-Protein A (10’ cpm) for 1 h. After 3 washes in PBS 
0.1% BSA, cells were lysed with NaOH (0.5 N). Radioactivity bound 
to the cells was determined in a y-radiation spectrometer. When men- 
tioned, junctional complexes were disrupted by incubating the cells in 
Ca2+-free medium for 1 h at 37°C according to Godefroy et al. [22]. 
2.7. Immunofluorescence studies 
Indirect immunofluorescence was performed as previously describ- 
ed 1171. 
3. RESULTS AND DISCUSSION 
The ability of HT29-D4 cells to synthesize CD4 
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Fig. 1. Immunoprecipitation of metabolically labeled cell lysates. 5 x 
10’ HT29-D4 cells were labeled for 3 h with 200 pCi .rnl-’ L- 
[35S]methionine and the lysate (lane 1) was immunoprecipitated using 
10 pg of control (lane 2), anti-HLA class I (lane 3), 13B8.2 (lane 4) 
or B14 (lane 5) in the presence of Protein A-Sepharose. Samples were 
then analyzed by SDS-PAGE and autoradiography. 
molecules was investigated by using radioim- 
munoprecipitation techniques. In a first set of ex- 
periments, the cells were incubated in the presence of 
L-[35S]methionine, then lysed with detergent and im- 
munoprecipitated with two different monoclonal an- 
tibodies directed against CD4 molecules, namely 
13B8.2 and B14. As shown in the autoradiogram in 
Fig. 1, a major polypeptide with an apparent M, of 
60000 was- specifically precipitated by these 
monoclonal antibodies (lanes 4 and 5). The other bands 
were presumably non-specifically precipitated because 
they were also observed after incubation of the labeled 
lysate with an irrelevant antibody (lane 2). An anti- 
HLA class I monoclonal antibody was used as a con- 
trol, it immunoprecipitated two labeled polypeptides of 
41 kDa and 12 kDa corresponding respectively to the 
HLA class I chain and the ,&-microglobulin associated 
polypeptide (lane 3). No labeled protein with an ap- 
parent M, of 60000 was detected using this antibody. 
In a second set of experiments HT29-D4 cell surface 
proteins were radioiodinated with Na”‘I using the lac- 
toperoxidase technique. After solubilization and im- 
munoprecipitation with 13B8.2 and B14, a single 
polypeptide of Mr 60000 was specifically detected on 
the autoradiogram (Fig. 2A, lanes 3 and 4). The 
specificity of this immunoprecipitation reaction was 
assessed by using an irrelevant antibody (lane 1) or the 
anti-HLA class I antibody (lane 2) that immunoselected 
the HLA class I-,&-microglobulin complex. In both 
cases, no detectable band was seen in the 60000 region 
of the gel. A similar experiment was performed on 
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Pig. 2. ~rnunoprec~p~~~~~ after celi surface fabeling at HT29D4 
and CEM cells. HTWD4 (A) and CEM (8) &Is were ~dj~i~nat~d 
using Ia~t~per~~~se. After soIubiIi~ti~R~ the &sates were 
irnrn~n~pr~ipitat~ using 10 pg of control (Ianes AI, Bl), anti-HLA 
class I (Ianes A2, B2), 13B8.2 flanes A3, 83) or Bf4 {Ianes A4, B4) 
in the presence of Protein A-Sephsruse. Samples were then analyzed 
by SDS-PAGE and dried gels were autoradiographed at -8OOC 
between intensifying screens. 
human l~pbobl~ti~ cells CEM, which are known to 
express the CD4 antigen on their plasma membrane 
1231. The results shown in Pig. 2B (lanes 3 and 4) 
demonstrate hat a single polypeptide with an apparent 
.&Jr of ~~ was also specifically detected in these cells 
after immunoprecipitation with 13B8.2 and Bl4. 
Therefore, the 60 kDa polypeptide im- 
munoprecipit~ted with 13Bg.2 and Bl4 after both 
metabolic and cell surface labeling of HT29D4 cells is 
likely the CD4 protein coded by the CD4 mRNA iden- 
tified in HT29 cells by Adachi et al, 1131. 
The establishment of a differ~tiated state of the 
clonal HT29-D4 cells can be obtained by a simple 
change of tbe carbon source in the cuit~re medium, 
namely the replacement of glucose by galactose 1161. 
When grown in glucose-free, ~a~tose-~o~t~~i~g 
m~dinrn~ the cells form a polarized monolayer with 
numerous domes indicative of a functional epithelial 
differentiation fl6,17]. At the structural level the cells 
exhibit a typical enterocytic differentiation ~hara~eriz- 
ed by an apical brush border facing the medium, with 
well organized microvilli and matnre junctional com- 
plexes that divide the cell membrane in two indepen- 
dent domains, i.e. apical and basolateral [16,17,19]. 
These two domains differ strongly in their protein con- 
tent as demonstrate by radioiodinatio~ and im- 
munoprecipitation studies: sucrase-isomaltase, alkaline 
phosphatase and CPA are localized on the apical eel1 
membrane whereas the VIP receptor, the transferrin 
receptor and the HLA class X antigen are restricted to 
the basolater~ domain (fl7,19] and in press). 
The loc~i~~tion f CR4 molecules in dome-forming 
TabIe I 
Radidmmunaassay on differentiated WKWD4 cells 
MonocIonal ~tib~dy cpm bound 
Apical binding’ Total bindingb 
Anti-vi&r 140s I8 220 * 36 
Anti-aikaiine phosphatase fIO7J & 510 lOlId * I317 
Anti-HLA class X x931 f 51 13914 f 708 
An&CD4* 199s * 107 7032 f 339 
After treatment with Ca’“-containin [a) or Ca”-Free rb) media, 
dame-forming HT29-D4 celIs were incubated for 2 h at I3OC in the 
presence of the indicated antibody and in the ease of mouoclonal 
anti-vifhn antibodies with rabbit anti-mouse IgGr . After two washes, 
‘%-Protein A was added (10’ cpm) for I h at 13°C. Radioactivity 
bound to ceils was deter~ned after lysinp the cells in NaOH (0.5 N). 
Results are exp#s~ as mean f SD of 2 separate ex~riments 
performed in duplieate. * B14 
HT2PD4 cells was investigated using a radioim- 
munoassay involving ‘2’I-Protein A as revealing agent. 
Specific apical binding was matured after incubation 
of HT29-D4 cells in Ca2+-containing medium and com- 
pared with the total specific binding obtained after 
pr~~~~bation f ceils in Ca2+-free medium to open 
tight junctions 1221. Non-specific binding was 
measured using a monoclonal antibody directed against 
villin, a ~~oskel~~ protein. Results hown in Table I 
demonstrate hat the binding of a monoclonal antibody 
recognizing an apical protein (e.g. alkaline 
~hos~bat~e~ is similar with or ~tb~~t reatment in 
Cat+-free medium. On the contrary, a basolateral 
marker (e.g. HLA class I antigens i  not accessible toa 
specific mono~lo~al ntibody because tight junctions 
prevent he antibody access to the basolateral side of 
the cells. In Ca2+-free medium, these junctions open 
and a free access is allowed to basolateral proteins. 
Thus, binding of anti-HLA class I antibodies is much 
more important when done on HT29-D4 celis prein- 
cubated in a rn~~urn devoid of Ca’+. This result is in 
agreement with the known basolateral restriction of 
HLA class I molecules in these cells 117,221 as well as 
in normal intestinal e~~theli~ 1241. 
The binding of anti-CD4 monocfonal antibody B14 is 
also strongly unhanded after opening tight junctions, 
indicating that most of CD4 molecules were restricted 
to the basolateral domain of polarized HT29D4 cells, 
It should be noted that the failure to detect any signifi- 
cant minding of its-~llin antibodies rules out the 
possibility of an eventual toxicity of the Cat+-free 
medium that could have led to a free access of anti-CD4 
antibodies to iatra~ellular rather than bas~later~ 
proteins, 
We also ~rform~ indiiect imrn~~~~uoresce~ce us- 
ing the anti-CD4 antibody to visualize the distribution 
of CD4 molecules at the surface of differentiated 
HT29-D4 cells, As control antibodies, anti-CEA and 
anti-HLA class I were also tested. These data are shown 
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Fig. 3. Immuno~uorescent s aining of differ~tiated HT29-D4 ceils. HT29-D4 cells were induced to differentiate in glucose-free, galactose- 
containing medium and cultured on glass coverslips until dome formation was observed in post-confluent monolayers. Cells were preincubated 
in Ca*+-containing (A-D) or Ca*+-free (E-H) medium and immunolabeled using anti-CEA (A, E), anti-HLA (B, F), 13B8.2 (C, G) or B14 (D, 
H) and FITC rabbit anti-mouse IgG. When pretreated with Ca2+ -containing medium, HT29-D4 cells were stained only with the anti-CEA 
monoclonal antibody (A) since the tight junctions prevented the access of anti-HLA (B), 13B8.2 (C) and B14 (D) to the basolateral membrane. 
After treatment in Ca’+-free medium, tight junctions were opened and basolateral membrane were uniformly stained with anti-HLA (F), 13B8.2 
(G) and B14 (H). The labeling with anti-CEA remained apical even after the junctions were disrupted (E). Bars: 20pm (A-G); 50 pm (H). 
- 
in Fig. 3. When the experiment was performed on in- 
tact dome-forming HT29-D4 cells, using an anti-CEA 
monoclonal antibody, a typical punctated fluorescence, 
characteristic of an apical labeling viewed en face 
(Fig. 3A). On the contrary, no detectable fluorescence 
was obtained when anti-HLA class I antibodies were 
used unless the junctional complexes were disrupted in 
the presence of Ca2+-free medium for 1 h at 37°C 
(Fig. 3B and F). The membrane distribution of CD4 
molecules behaved like HLA class I molecules because 
the fluorescent labeling with the two monoclonal an- 
tibodies directed against CD4 (i.e. 13B8.2 and B14) was 
detected exclusively on Ca2”-free medium pretreated 
cells (Fig. 3G and H), in agreement with the data we 
obtained using radioimmunoassay (Table I). All these 
data are consistent with a basolateral ocalization of 
CD4 molecules at the surface of polarized HT29-D4 
cells. 
Because HT29-D4 cells can be readily grown on 
permeable filters where they form leakproof electrically 
active monolayers [ 17,19,25], we will take advantage of 
this culture method that gives independent access to 
each domain of the cell membrane to try to selectively 
infect HT29-D4 cells with HIV by the basolateral mem- 
brane domain which contains CD4 molecules (as 
demonstrated in the paper) or by the apical domain as 
a control infection. The polarized expression of virus 
envelope proteins [26] will be studied in this model. In 
conclusion, the HT29-D4 clone will undoubtedly be a 
useful model to study the infection of colonic epithelial 
cells by HIV and to help understand more precisely 
some of the gastrointestinal disorders described in 
AIDS patients [lo-121. 
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